First Turn Management »

Palvella Therapeutics Inc Ne shares owned by First Turn Management

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by First Turn Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $19M 148k 124.65

More positions owned by First Turn Management

United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Bridgebio Pharma (BBIO)
Xenon Pharmaceuticals (XENE)
Revolution Medicines (RVMD)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Nuvalent Inc-a (NUVL)
Mirum Pharmaceuticals (MIRM)
Cogent Biosciences (COGT)
Roivant Sciences SHS (ROIV)
Axsome Therapeutics (AXSM)
Ideaya Biosciences (IDYA)
Oric Pharmaceuticals (ORIC)
Enliven Therapeutics (ELVN)

View all positions for First Turn Management

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Capital Management
State Street Corporation
Federated Investors
Frontier Capital Management
Woodline Partners
Alliancebernstein
Siren
Caption Management
Eventide Asset Management

View all funds holding Palvella Therapeutics Inc Ne